Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Defective interfering virus protects elderly mice from influenza

Authors: Paul D Scott, Bo Meng, Anthony C Marriott, Andrew J Easton, Nigel J Dimmock

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

We have identified and characterised a defective-interfering (DI) influenza A virus particles containing a highly deleted segment 1 RNA that has broad-spectrum antiviral activity. In young adult mice it exerts protection against several different subtypes of influenza A virus (defined here as homologous or genetically compatible protection) and against a paramyxovirus and an influenza B virus (heterologous or genetically unrelated protection). Homologous protection is mediated by replication competition between the deleted and full-length genomes, and heterologous protection occurs through stimulation of innate immunity, especially interferon type I.

Methods

A single dose of the protective DI virus was administered intranasally to elderly mice at -7, -1 and +1 days relative to intranasal challenge with influenza A virus.

Results

A single dose of the DI virus given 1 or 7 days protected elderly mice, reducing a severe, sometimes fatal disease to a subclinical or mild infection. In contrast, all members of control groups treated with inactivated DI virus before challenge became extremely ill and most died. Despite the subclinical/mild nature of their infection, protected mice developed solid immunity to a second infectious challenge.

Conclusions

The defective interfering virus is effective in preventing severe influenza A in elderly mice and may offer a new approach to protection of the human population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Treanor JJ, Falsey A: Respiratory viral infections in the elderly. Antiviral Research 1999, 44: 79-102. 10.1016/S0166-3542(99)00062-5CrossRefPubMed Treanor JJ, Falsey A: Respiratory viral infections in the elderly. Antiviral Research 1999, 44: 79-102. 10.1016/S0166-3542(99)00062-5CrossRefPubMed
2.
go back to reference Webster RG: Immunity to influenza in the elderly. Vaccine 2000, 18: 1686-1689. 10.1016/S0264-410X(99)00507-1CrossRefPubMed Webster RG: Immunity to influenza in the elderly. Vaccine 2000, 18: 1686-1689. 10.1016/S0264-410X(99)00507-1CrossRefPubMed
3.
go back to reference Falsey A, Dallal G, Formica M, Andolina G, Hamer D, Leka L, Meydani S: Long-term care facilities: A cornucopia of viral pathogens. Journal of the American Geriatrics Society 2008, 56: 1281-1285. 10.1111/j.1532-5415.2008.01775.xPubMedCentralCrossRefPubMed Falsey A, Dallal G, Formica M, Andolina G, Hamer D, Leka L, Meydani S: Long-term care facilities: A cornucopia of viral pathogens. Journal of the American Geriatrics Society 2008, 56: 1281-1285. 10.1111/j.1532-5415.2008.01775.xPubMedCentralCrossRefPubMed
4.
go back to reference Yoshikawa TT, Norman DC: Infectious disease in the aging. Towota, NJ: Humana Press; 2000.CrossRef Yoshikawa TT, Norman DC: Infectious disease in the aging. Towota, NJ: Humana Press; 2000.CrossRef
5.
go back to reference Canaday D, Amponsah N, Jones L, Tisch D, Hornick T, Ramachandra L: Influenza-induced production of interferon-α is defective in geriatric individuals. Journal of Clinical Immunology 2010, 30: 373-383. 10.1007/s10875-010-9374-9PubMedCentralCrossRefPubMed Canaday D, Amponsah N, Jones L, Tisch D, Hornick T, Ramachandra L: Influenza-induced production of interferon-α is defective in geriatric individuals. Journal of Clinical Immunology 2010, 30: 373-383. 10.1007/s10875-010-9374-9PubMedCentralCrossRefPubMed
6.
go back to reference Fujihashi K, Koga T, McGhee JR: Mucosal vaccination and immune responses in the elderly. Vaccine 2000, 18: 1675-1680. 10.1016/S0264-410X(99)00505-8CrossRefPubMed Fujihashi K, Koga T, McGhee JR: Mucosal vaccination and immune responses in the elderly. Vaccine 2000, 18: 1675-1680. 10.1016/S0264-410X(99)00505-8CrossRefPubMed
7.
go back to reference Fulop T, Pawelec G, Castle S, Loeb M: Immunosenescence and vaccination in nursing home residents. Clinical Infectious Diseases 2009, 48: 443-448. 10.1086/596475CrossRefPubMed Fulop T, Pawelec G, Castle S, Loeb M: Immunosenescence and vaccination in nursing home residents. Clinical Infectious Diseases 2009, 48: 443-448. 10.1086/596475CrossRefPubMed
8.
go back to reference Huang YP, Pechere JC, Michel M, Gauthey L, Loreto M, Curran JA, Michel JP: In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. Journal of Immunology 1992, 148: 715-722. Huang YP, Pechere JC, Michel M, Gauthey L, Loreto M, Curran JA, Michel JP: In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. Journal of Immunology 1992, 148: 715-722.
9.
go back to reference Joshi SR, Shaw AC, Quagliarello VJ: Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine. Yale Journal of Biology and Medicine 2009, 82: 143-151.PubMedCentralPubMed Joshi SR, Shaw AC, Quagliarello VJ: Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine. Yale Journal of Biology and Medicine 2009, 82: 143-151.PubMedCentralPubMed
10.
go back to reference Kovaiou RD, Grubeck-Loebenstein B: Age-associated changes within CD4+ T cells. Immunology Letters 2006, 107: 8-14. 10.1016/j.imlet.2006.07.006CrossRefPubMed Kovaiou RD, Grubeck-Loebenstein B: Age-associated changes within CD4+ T cells. Immunology Letters 2006, 107: 8-14. 10.1016/j.imlet.2006.07.006CrossRefPubMed
11.
go back to reference Mbawuike IN, Lange AR, Couch RB: Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunology 1993, 6: 55-64. 10.1089/vim.1993.6.55CrossRefPubMed Mbawuike IN, Lange AR, Couch RB: Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunology 1993, 6: 55-64. 10.1089/vim.1993.6.55CrossRefPubMed
12.
go back to reference Reis e Sousa C: Dendritic cells in a mature age. Nature Reviews in Immunology 2007, 6: 476-483.CrossRef Reis e Sousa C: Dendritic cells in a mature age. Nature Reviews in Immunology 2007, 6: 476-483.CrossRef
13.
go back to reference Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD, Carlone GM: Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clinical and Infectious Disease 1999, 29: 281-288. 10.1086/520200CrossRef Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD, Carlone GM: Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clinical and Infectious Disease 1999, 29: 281-288. 10.1086/520200CrossRef
14.
go back to reference Vallejo AN: Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged. Immunological Research 2007, 36: 221-228.CrossRef Vallejo AN: Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged. Immunological Research 2007, 36: 221-228.CrossRef
15.
go back to reference Whitley RJ, Monto AS: Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. Journal of Infectious Diseases 2006,194(S2):S133-S138. 10.1086/507548CrossRefPubMed Whitley RJ, Monto AS: Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. Journal of Infectious Diseases 2006,194(S2):S133-S138. 10.1086/507548CrossRefPubMed
16.
go back to reference Elliot A, Fleming D: Influenza and respiratory syncytial virus in the elderly. Expert Review of Vaccines 2008, 7: 249-258. 10.1586/14760584.7.2.249CrossRefPubMed Elliot A, Fleming D: Influenza and respiratory syncytial virus in the elderly. Expert Review of Vaccines 2008, 7: 249-258. 10.1586/14760584.7.2.249CrossRefPubMed
17.
go back to reference Cox NJ, Subbarao K: Influenza. The Lancet 1999, 354: 1277-1282. 10.1016/S0140-6736(99)01241-6CrossRef Cox NJ, Subbarao K: Influenza. The Lancet 1999, 354: 1277-1282. 10.1016/S0140-6736(99)01241-6CrossRef
18.
go back to reference Wilson IA, Cox NJ: Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 1990, 8: 737-771. 10.1146/annurev.iy.08.040190.003513CrossRefPubMed Wilson IA, Cox NJ: Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 1990, 8: 737-771. 10.1146/annurev.iy.08.040190.003513CrossRefPubMed
19.
go back to reference Gross PA, Hermogenes A, Sacks HS, Lau J, Levandowski RA: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Annals of Internal Medicine 1995, 123: 518-527.CrossRefPubMed Gross PA, Hermogenes A, Sacks HS, Lau J, Levandowski RA: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Annals of Internal Medicine 1995, 123: 518-527.CrossRefPubMed
20.
go back to reference Jefferson T, Rivetti D, Rudin M, Di Pietrantonj C, Demicheli V: Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366: 1165-1174. 10.1016/S0140-6736(05)67339-4CrossRefPubMed Jefferson T, Rivetti D, Rudin M, Di Pietrantonj C, Demicheli V: Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366: 1165-1174. 10.1016/S0140-6736(05)67339-4CrossRefPubMed
21.
go back to reference Goodwin K, Viboud C, Simonsen L: Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24: 1159-1169. 10.1016/j.vaccine.2005.08.105CrossRefPubMed Goodwin K, Viboud C, Simonsen L: Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24: 1159-1169. 10.1016/j.vaccine.2005.08.105CrossRefPubMed
22.
go back to reference Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE: Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2010,2(2):CD004876.PubMed Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE: Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2010,2(2):CD004876.PubMed
23.
go back to reference Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R: Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database of Systematic Reviews, Issue 2, article number CD001265 2010. Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R: Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database of Systematic Reviews, Issue 2, article number CD001265 2010.
24.
go back to reference McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA: Influenza (H5N1) with decreased oseltamivir sensitivity, Indonesia. Emerging Infectious Diseases 2007, 13: 1354-1357.PubMedCentralCrossRefPubMed McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA: Influenza (H5N1) with decreased oseltamivir sensitivity, Indonesia. Emerging Infectious Diseases 2007, 13: 1354-1357.PubMedCentralCrossRefPubMed
25.
go back to reference Monto A: Implications of antiviral resistance of influenza viruses. Clinical Infectious Diseases 2009, 48: 397-399. 10.1086/596312CrossRefPubMed Monto A: Implications of antiviral resistance of influenza viruses. Clinical Infectious Diseases 2009, 48: 397-399. 10.1086/596312CrossRefPubMed
26.
go back to reference Aoki FY, Boivin G, Roberts N: Influenza virus susceptibility and resistance to oseltamivir. Antiviral Therapy 2007, 12: 603-616.PubMed Aoki FY, Boivin G, Roberts N: Influenza virus susceptibility and resistance to oseltamivir. Antiviral Therapy 2007, 12: 603-616.PubMed
27.
go back to reference Holland JJ: Defective viral genomes. In Virology. Volume 1. 2nd edition. Edited by: Fields BN, Knipe DM. New York: Raven Press; 1990:151-165. Holland JJ: Defective viral genomes. In Virology. Volume 1. 2nd edition. Edited by: Fields BN, Knipe DM. New York: Raven Press; 1990:151-165.
28.
go back to reference Holland JJ: Generation and replication of defective viral genomes. In Virology. 2nd edition. Edited by: Fields BN, Knipe DM. New York: Raven Press; 1990:77-99. Holland JJ: Generation and replication of defective viral genomes. In Virology. 2nd edition. Edited by: Fields BN, Knipe DM. New York: Raven Press; 1990:77-99.
29.
go back to reference Huang AS, Baltimore D: Defective viral particles and viral disease processes. Nature (London) 1970, 226: 325-327. 10.1038/226325a0CrossRef Huang AS, Baltimore D: Defective viral particles and viral disease processes. Nature (London) 1970, 226: 325-327. 10.1038/226325a0CrossRef
30.
go back to reference Nayak DP, Chambers TM, Akkina RM: Structure of defective-interfering RNAs of influenza virus and their role in interference. In The Influenza Viruses. Edited by: Krug RM. New York: Plenum Press; 1989:269-317.CrossRef Nayak DP, Chambers TM, Akkina RM: Structure of defective-interfering RNAs of influenza virus and their role in interference. In The Influenza Viruses. Edited by: Krug RM. New York: Plenum Press; 1989:269-317.CrossRef
31.
go back to reference Perrault J: Origin and replication of defective interfering particles. Current Topics in Microbiology and Immunology 1981, 93: 151-207.PubMed Perrault J: Origin and replication of defective interfering particles. Current Topics in Microbiology and Immunology 1981, 93: 151-207.PubMed
32.
go back to reference von Magnus P: Incomplete forms of influenza virus. Advances in Virus Research 1954, 21: 59-79.CrossRef von Magnus P: Incomplete forms of influenza virus. Advances in Virus Research 1954, 21: 59-79.CrossRef
33.
go back to reference Nayak DP, Chambers TM, Akkina RK: Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression and interference. Current Topics in Microbiology and Immunology 1985, 114: 103-151.PubMed Nayak DP, Chambers TM, Akkina RK: Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression and interference. Current Topics in Microbiology and Immunology 1985, 114: 103-151.PubMed
34.
go back to reference Jennings PA, Finch JT, Winter G, Robertson JS: Does the higher order of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA. Cell 1983, 34: 619-627. 10.1016/0092-8674(83)90394-XCrossRefPubMed Jennings PA, Finch JT, Winter G, Robertson JS: Does the higher order of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA. Cell 1983, 34: 619-627. 10.1016/0092-8674(83)90394-XCrossRefPubMed
35.
go back to reference Duhaut SD, Dimmock NJ: Heterologous protection against a lethal human H1N1 influenza virus infection of mice by a H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Virology 1998, 248: 241-253. 10.1006/viro.1998.9267CrossRefPubMed Duhaut SD, Dimmock NJ: Heterologous protection against a lethal human H1N1 influenza virus infection of mice by a H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Virology 1998, 248: 241-253. 10.1006/viro.1998.9267CrossRefPubMed
36.
go back to reference Dimmock NJ, Rainsford EW, Scott PD, Marriott AC: Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. Journal of Virology 2008, 82: 8570-8578. 10.1128/JVI.00743-08PubMedCentralCrossRefPubMed Dimmock NJ, Rainsford EW, Scott PD, Marriott AC: Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. Journal of Virology 2008, 82: 8570-8578. 10.1128/JVI.00743-08PubMedCentralCrossRefPubMed
37.
go back to reference Marriott AC, Dimmock NJ: Defective interfering viruses and their potential as antiviral agents. Reviews in Medical Virology 2010, 20: 51-62. 10.1002/rmv.641CrossRefPubMed Marriott AC, Dimmock NJ: Defective interfering viruses and their potential as antiviral agents. Reviews in Medical Virology 2010, 20: 51-62. 10.1002/rmv.641CrossRefPubMed
38.
go back to reference Toapanta FR, Ross TM: Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory Research 2009, 10: 112. 10.1186/1465-9921-10-112PubMedCentralCrossRefPubMed Toapanta FR, Ross TM: Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory Research 2009, 10: 112. 10.1186/1465-9921-10-112PubMedCentralCrossRefPubMed
39.
go back to reference Wen ZY, Ye L, Gao YL, Pan L, Dong K, Bu ZG, Compans RW, Yang CL: Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Research 2009, 84: 215-224. 10.1016/j.antiviral.2009.09.005PubMedCentralCrossRefPubMed Wen ZY, Ye L, Gao YL, Pan L, Dong K, Bu ZG, Compans RW, Yang CL: Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Research 2009, 84: 215-224. 10.1016/j.antiviral.2009.09.005PubMedCentralCrossRefPubMed
40.
go back to reference Dong L, Mori I, Hossain MJ, Kimura Y: The senescence-accelerated mouse shows aging-related defects in cellular but not humoral imunity against influenza virus. Journal of Infectious Diseases 2000, 182: 391-396. 10.1086/315727CrossRefPubMed Dong L, Mori I, Hossain MJ, Kimura Y: The senescence-accelerated mouse shows aging-related defects in cellular but not humoral imunity against influenza virus. Journal of Infectious Diseases 2000, 182: 391-396. 10.1086/315727CrossRefPubMed
41.
go back to reference Dong L, Mori I, Hossain MJ, Liu B, Kimura Y: An immunostimulatory oligodeooxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. Journal of General Virology 2003, 84: 1623-1628. 10.1099/vir.0.19029-0CrossRefPubMed Dong L, Mori I, Hossain MJ, Liu B, Kimura Y: An immunostimulatory oligodeooxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. Journal of General Virology 2003, 84: 1623-1628. 10.1099/vir.0.19029-0CrossRefPubMed
42.
go back to reference Effros RB, Walford RL: The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cellular Immunolology 1983, 81: 298-305. 10.1016/0008-8749(83)90237-XCrossRef Effros RB, Walford RL: The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cellular Immunolology 1983, 81: 298-305. 10.1016/0008-8749(83)90237-XCrossRef
43.
go back to reference Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM: Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mechanisms of Ageing and Development 2002, 123: 1167-1181. 10.1016/S0047-6374(02)00010-6CrossRefPubMed Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM: Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mechanisms of Ageing and Development 2002, 123: 1167-1181. 10.1016/S0047-6374(02)00010-6CrossRefPubMed
44.
go back to reference Zheng B, Zhang Y, He H, Marinova E, Switzer K, Wansley D, Mbawuike I, Han S: Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes. Journal of Immunology 2007, 179: 6153-6159.CrossRef Zheng B, Zhang Y, He H, Marinova E, Switzer K, Wansley D, Mbawuike I, Han S: Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes. Journal of Immunology 2007, 179: 6153-6159.CrossRef
45.
go back to reference Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, Dimmock NJ: A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 2011, 29: 2777-2784. 10.1016/j.vaccine.2011.01.102CrossRefPubMed Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, Dimmock NJ: A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 2011, 29: 2777-2784. 10.1016/j.vaccine.2011.01.102CrossRefPubMed
Metadata
Title
Defective interfering virus protects elderly mice from influenza
Authors
Paul D Scott
Bo Meng
Anthony C Marriott
Andrew J Easton
Nigel J Dimmock
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-212

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.